250 related articles for article (PubMed ID: 19961757)
1. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
Zhang G; Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
3. Dual role of podoplanin in oral cancer development.
Cîrligeriu L; Cimpean AM; Raica M; Doroş CI
In Vivo; 2014; 28(3):341-7. PubMed ID: 24815836
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin expression in oral leukoplakia: tumorigenic role.
de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
Zhang J; Zeng Y; Zheng J; Xu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
[TBL] [Abstract][Full Text] [Related]
7. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
[TBL] [Abstract][Full Text] [Related]
8. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes.
de Sousa SF; Gleber-Netto FO; de Oliveira-Neto HH; Batista AC; Nogueira Guimarães Abreu MH; de Aguiar MC
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):588-94. PubMed ID: 22495364
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
[TBL] [Abstract][Full Text] [Related]
11. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
Liang X; Mao Z; He Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.
Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T
Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Wu YC; Chao YK; Liu YH; Tseng CK; Chang HK; Liu HP; Hsueh C
Histol Histopathol; 2009 Aug; 24(8):1021-7. PubMed ID: 19554509
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
17. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.
Tong L; Yuan S; Feng F; Zhang H
Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849
[TBL] [Abstract][Full Text] [Related]
18. Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis.
Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
Head Neck; 2017 Jan; 39(1):98-108. PubMed ID: 27437903
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
20. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ].
Babichenko II; Grigor'ian AS; Katushkina AA
Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]